Insulin-like Growth Factor II Plays a Central Role in Atherosclerosis in a Mouse Model
Open Access
- 1 February 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (6) , 4505-4511
- https://doi.org/10.1074/jbc.m108061200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- AtherosclerosisCell, 2001
- Relaxation of Insulin-like Growth Factor 2 Imprinting and Discordant Methylation at KvDMR1 in Two First Cousins Affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber SyndromesAmerican Journal of Human Genetics, 2000
- Reconstituted HDL Containing Human Apolipoprotein A-1 Reduces VCAM-1 Expression and Neointima Formation Following Periadventitial Cuff-Induced Carotid Injury in apoE Null MiceBiochemical and Biophysical Research Communications, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith–Wiedemann and Simpson–Golabi–Behmel syndromesGenes & Development, 1997
- Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.Journal of Clinical Investigation, 1997
- Involvement of IGF-II in human cancerJournal of Endocrinology, 1996
- Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndromeNature Genetics, 1996
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targetingNature, 1990